Neuraxis (NRXS) Asset Utilization Ratio (2023 - 2025)
Neuraxis (NRXS) posted Asset Utilization Ratio of 0.59 for Q4 2025, up 12.12% sequentially from 0.52 in Q3 2025, and down 35.62% YoY from 0.91 in Q4 2024.
Neuraxis (NRXS) Asset Utilization Ratio (2023 - 2025) Analysis & Trends
Neuraxis has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.59 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 35.62% year-over-year to 0.59 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.59 (down 35.62% YoY) and the FY2025 annual result came in at 0.64, down 37.29% from the prior year.
- Asset Utilization Ratio grew to 0.59 in Q4 2025 per NRXS's latest filing, from 0.52 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 3.16 in Q1 2024 and troughed at 0.52 in Q3 2025.
- A 3-year average of 1.38 and a median of 1.09 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio declined 28.98% in 2024, then sank 76.17% in 2025.
- Over 3 years, Asset Utilization Ratio stood at 2.82 in 2023, then plunged by 67.71% to 0.91 in 2024, then plunged by 35.62% to 0.59 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.59, 0.52, and 0.64 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Neuraxis | 74.54 Mn | 66.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.75 |
| Dec 31, 2024 | 0.91 |
| Sep 30, 2024 | 1.30 |
| Jun 30, 2024 | 1.27 |
| Mar 31, 2024 | 3.16 |
| Dec 31, 2023 | 2.82 |
| Sep 30, 2023 | 1.83 |